Morten Herholdt
Stock Analyst at HSBC
(3.46)
# 1,068
Out of 4,497 analysts
16
Total ratings
72.73%
Success rate
0.24%
Average return
Main Sectors:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $178.58 | +25.99% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $226.40 | +51.06% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $72.56 | -4.91% | 2 | Apr 24, 2024 | |
| JNJ Johnson & Johnson | Upgrades: Buy | $169 → $170 | $154.69 | +9.90% | 2 | Apr 18, 2024 | |
| BLUE bluebird bio | Maintains: Reduce | $2.31 → $1.02 | $1.05 | -2.86% | 2 | Mar 5, 2024 | |
| LH Labcorp Holdings | Initiates: Hold | $210 | $211.37 | -0.65% | 1 | Sep 6, 2023 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $565.33 | -4.48% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $52.91 | -1.72% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $224.57 | +15.78% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $331.29 | -3.41% | 1 | Sep 6, 2023 | |
| ATNM Actinium Pharmaceuticals | Initiates: Buy | $12 | $7.11 | +63.15% | 1 | Sep 6, 2023 |
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $178.58
Upside: +25.99%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $226.40
Upside: +51.06%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $72.56
Upside: -4.91%
Johnson & Johnson
Apr 18, 2024
Upgrades: Buy
Price Target: $169 → $170
Current: $154.69
Upside: +9.90%
bluebird bio
Mar 5, 2024
Maintains: Reduce
Price Target: $2.31 → $1.02
Current: $1.05
Upside: -2.86%
Labcorp Holdings
Sep 6, 2023
Initiates: Hold
Price Target: $210
Current: $211.37
Upside: -0.65%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $565.33
Upside: -4.48%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $52.91
Upside: -1.72%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $224.57
Upside: +15.78%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $331.29
Upside: -3.41%
Actinium Pharmaceuticals
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $7.11
Upside: +63.15%